Cargando…
Notch signaling in glioblastoma: a developmental drug target?
Malignant gliomas are among the most devastating tumors for which conventional therapies have not significantly improved patient outcome. Despite advances in imaging, surgery, chemotherapy and radiotherapy, survival is still less than 2 years from diagnosis and more targeted therapies are urgently n...
Autores principales: | Lino, Maria Maddalena, Merlo, Adrian, Boulay, Jean-Louis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996337/ https://www.ncbi.nlm.nih.gov/pubmed/21078177 http://dx.doi.org/10.1186/1741-7015-8-72 |
Ejemplares similares
-
PI3Kinase signaling in glioblastoma
por: Lino, M. M., et al.
Publicado: (2010) -
Role of Notch Signaling Pathway in Glioblastoma Pathogenesis
por: Bazzoni, Riccardo, et al.
Publicado: (2019) -
Post-Developmental Roles of Notch Signaling in the Nervous System
por: Salazar, Jose L., et al.
Publicado: (2020) -
GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
por: Korur, Serdar, et al.
Publicado: (2009) -
Notch intracellular domain regulates glioblastoma proliferation through the Notch1 signaling pathway
por: Wang, Yixuan, et al.
Publicado: (2021)